arrow
Back
V

V.P. Stus

Ankara University

19H-index
81Paper Count
6.7KCitation Count
Published Papers 12
Publication Date
Pembrolizumab plus lenvatinib for previously untreated advanced non-clear cell renal cell carcinoma: 3-year follow-up of the phase 2 KEYNOTE-B61 study
err2025-10-01
err2
errOAAI
errAlbiges, Laurence; Gurney, Howard; Lee, Jae Lyun; Atduev, Vagif; Suarez, Cristina; Climent, Miguel A.; Pook, David; Tomczak, Piotr; Barthelemy, Philippe; Gedye, Craig; Lacombe, Louis; Ferguson, Thomas; Stus, Viktor; Wiechno, Pawel; Erman, Mustafa; Urun, Yuksel; Cornell, Jerry; Burgents, Joe; Sharma, Manish; Voss, Martin
errShare
errSave
Pembrolizumab plus axitinib versus sunitinib for advanced clear cell renal cell carcinoma: 5-year survival and biomarker analyses of the phase 3 KEYNOTE-426 trial
err2025-08-01
err0
errOAAI
errBrian I. Rini; Elizabeth R. Plimack; Viktor Stus; Rustem Gafanov; Tom Waddell; Dmitry Nosov; Frédéric Pouliot; Boris Alekseev; Denis Soulières; Bohuslav Melichar; Ihor Vynnychenko; Sergio Jobim de Azevedo; Delphine Borchiellini; Raymond S. McDermott; Jens Bedke; Satoshi Tamada; Sterling Wu; Julia Markensohn; Yiwei Zhang; Andrey Loboda; Amir Vajdi; Rodolfo F. Perini; Joseph Burgents; Thomas Powles
errShare
errSave
First-line Pembrolizumab Plus Lenvatinib for Advanced Non–clear-cell Renal Cell Carcinoma: Updated Results from the Phase 2 KEYNOTE-B61 Trial
err2025-07-24
err0
PREAI
errMartin H. Voss; Howard Gurney; Vagif Atduev; Cristina Suarez; Miguel A. Climent; David Pook; Piotr Tomczak; Philippe Barthélémy; Jae Lyun Lee; Taron Nalbandian; Viktor Stus; Thomas Ferguson; Pawel Wiechno; Erhan Gokmen; Louis Lacombe; Craig Gedye; Jerry Cornell; Manish Sharma; Joseph E. Burgents; Laurence Albiges
errShare
errSave
Pembrolizumab Plus Axitinib Versus Sunitinib as First-line Treatment of Advanced Renal Cell Carcinoma: 43-month Follow-up of the Phase 3 KEYNOTE-426 Study[Eur Urol 84(5) (2023) 449-454]
err2023-12-01
err0
errOAAI
errPlimack, Elizabeth R.; Powles, Thomas; Stus, Viktor; Gafanov, Rustem; Nosov, Dmitry; Waddell, Tom; Alekseev, Boris; Pouliot, Frederic; Melichar, Bohuslav; Soulieres, Denis; Borchiellini, Delphine; McDermott, Raymond S.; Vynnychenko, Ihor; Chang, Yen-Hwa; Tamada, Satoshi; Atkins, Michael B.; Molife, L. Rhoda; Li, Chenxiang; Perini, Rodolfo; Bedke, Jens; Rini, Brian I.
errShare
errSave
Pembrolizumab Plus Axitinib Versus Sunitinib as First-line Treatment of Advanced Renal Cell Carcinoma: 43-month Follow-up of the Phase 3 KEYNOTE-426 Study
err2023-11-01
err30
PREAI
errPlimack, Elizabeth R.; Powles, Thomas; Stus, Viktor; Gafanov, Rustem; Nosov, Dmitry; Waddell, Tom; Alekseev, Boris; Pouliot, Frederic; Melichar, Bohuslav; Soulieres, Denis; Borchiellini, Delphine; Mcdermott, Raymond S.; Vynnychenko, Ihor; Chang, Yen-Hwa; Tamada, Satoshi; Atkins, Michael B.; Li, Chenxiang; Perini, Rodolfo; Molife, L. Rhoda; Bedke, Jens; Rini, Brian I.
errShare
errSave
Pembrolizumab Plus Axitinib Versus Sunitinib as First-line Treatment of Advanced Renal Cell Carcinoma: 43-month Follow-up of the Phase 3 KEYNOTE-426 Study ( vol 84 , pg , 449 , 2023)
err2023-11-01
err0
errOAAI
errPlimack, Elizabeth R.; Powles, Thomas; Stus, Viktor; Gafanov, Rustem; Nosov, Dmitry; Waddell, Tom; Alekseev, Boris; Poulioti, Frederic; Melichar, Bohuslav; Soulieres, Denis; Borchiellini, Delphine; McDermott, Raymond S.; Vynnychenko, Ihor; Chang, Yen-Hwa; Tamada, Satoshi; Atkins, Michael B.; Li, Chenxiang; Perini, Rodolfo; Molife, L. Rhoda; Bedke, Jens; Riniu, Brian I.
errShare
errSave
Health-related Quality of Life Analysis from KEYNOTE-426: Pembrolizumab plus Axitinib Versus Sunitinib for Advanced Renal Cell Carcinoma
err2022-10-01
err20
PREAI
errBedke, Jens; Rini, Brian, I; Plimack, Elizabeth R.; Stus, Viktor; Gafanov, Rustem; Waddell, Tom; Nosov, Dimitry; Pouliot, Frederic; Soulieres, Denis; Melichar, Bohuslav; Vynnychenko, Ihor; Azevedo, Sergio J.; Borchiellini, Delphine; McDermott, Raymond S.; Tamada, Satoshi; Nguyen, Allison Martin; Wan, Shuyan; Perini, Rodolfo F.; Molife, L. Rhoda; Atkins, Michael B.; Powles, Thomas
errShare
errSave
RESTORE-IMI 1: A Multicenter, Randomized, Double-blind Trial Comparing Efficacy and Safety of Imipenem/Relebactam vs Colistin Plus Imipenem in Patients With Imipenem-nonsusceptible Bacterial Infections
err2019-08-10
err290
errOAAI
errMotsch, Johann; de Oliveira, Claudia Murta; Stus, Viktor; Koksal, Iftihar; Lyulko, Olexiy; Boucher, Helen W.; Kaye, Keith S.; File, Thomas M., Jr.; Brown, Michelle L.; Khan, Ireen; Du, Jiejun; Joeng, Hee-Koung; Tipping, Robert W.; Aggrey, Angela; Young, Katherine; Kartsonis, Nicholas A.; Butterton, Joan R.; Paschke, Amanda
errShare
errSave
Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma
err2019-03-21
err2.4K
errOAAI
errRini, Brian I.; Plimack, Elizabeth R.; Stus, Viktor; Gafanov, Rustem; Hawkins, Robert; Nosov, Dmitry; Pouliot, Frederic; Alekseev, Boris; Soulieres, Denis; Melichar, Bohuslav; Vynnychenko, Ihor; Kryzhanivska, Anna; Bondarenko, Igor; Azevedo, Sergio J.; Borchiellini, Delphine; Szczylik, Cezary; Markus, Maurice; McDermott, Raymond S.; Bedke, Jens; Tartas, Sophie; Chang, Yen-Hwa; Tamada, Satoshi; Shou, Qiong; Perini, Rodolfo F.; Chen, Mei; Atkins, Michael B.; Powles, Thomas
errShare
errSave
Fosfomycin for Injection (ZTI-01) Versus Piperacillin-tazobactam for the Treatment of Complicated Urinary Tract Infection Including Acute Pyelonephritis: ZEUS, A Phase 2/3 Randomized Trial
err2019-03-06
err108
errOAAI
errKaye, Keith S.; Rice, Louis B.; Dane, Aaron L.; Stus, Viktor; Sagan, Olexiy; Fedosiuk, Elena; Das, Anita F.; Skarinsky, David; Eckburg, Paul B.; Ellis-Grosse, Evelyn J.
errShare
errSave
Effect of Meropenem-Vaborbactam vs Piperacillin-Tazobactam on Clinical Cure or Improvement and Microbial Eradication in Complicated Urinary Tract Infection The TANGO I Randomized Clinical Trial
err2018-02-27
err250
errOAAI
errKaye, Keith S.; Bhowmick, Tanaya; Metallidis, Symeon; Bleasdale, Susan C.; Sagan, Olexiy S.; Stus, Viktor; Vazquez, Jose; Zaitsev, Valerii; Bidair, Mohamed; Chorvat, Erik; Dragoescu, Petru Octavian; Fedosiuk, Elena; Horcajada, Juan P.; Murta, Claudia; Sarychev, Yaroslav; Stoev, Ventsislav; Morgan, Elizabeth; Fusaro, Karen; Griffith, David; Lomovskaya, Olga; Alexander, Elizabeth L.; Loutit, Jeffery; Dudley, Michael N.; Giamarellos-Bourboulis, Evangelos J.
errShare
errSave
Overall survival analysis from a randomised phase III trial of axitinib vs sorafenib as first-line therapy in patients with metastatic renal cell carcinoma
err2015-09-01
err3
PREAI
errHutson, T. E.; Al-Shukri, S.; Stus, V. P.; Lipatov, O. N.; Shparyk, Y.; Bair, A. H.; Rosbrook, B.; Andrews, G. I.; Vogelzang, N. J.
errShare
errSave